Sao Paulo's Governor Says Brazilians May Have Coronavirus Vaccine Soon

Sao Paulo State's Governor João Doria said that 'Phase 3 clinical trials of a COVID-19 vaccine candidate developed by Sinovac Biotech Ltd has shown promising results and it may be available to Brazilians as early as December 2020, reported Aljazeera on September 10, 2020. The vaccine trials in Brazil are being conducted by the Butantan Institute in Sao Paulo city and 11 other locations.

Sinovac's CoronaVac SARS-CoV-2 Vaccine candidate is based on an inactivated pathogen made by growing the whole virus in a lab and then killing it, which is how polio shots are made. The latest COVID-19 news regarding phase 3 vaccine studies is published at CoronavirvusToday.

As of September 10, 2020, the South American country of Brazil, with a population of about 212 million, had reported 128,623 fatalities related to COVID-19 pneumonia during 2020.